New York continues mpox vaccine and health awareness campaign
5 May 2024. Related: mpox (monkeypox).
2024
BHIVA Spring Conference (BHIVA 2024)
2 May 2024. Related: Conference reports.
Drug resistance or side effects might limit ART in up to 1 in 10 people living with HIV
2 May 2024. Related: Antiretrovirals, Treatment strategies, Side effects, Drug resistance.
ART in early infection stops further viral evolution
21 April 2024. Related: Antiretrovirals, Virology.
Australia Consensus Statement on doxy-PEP proposes limited use in gay and bisexual men
10 April 2024. Related: Guidelines, Coinfections and complications, Other news.
CROI 2024 now online and open access
10 April 2024. Related: Conference reports.
Uganda Court rejects appeal against the LGBTQ+ hate law
5 April 2024. Related: Special reports, Treatment access.
BHIVA best of CROI webinars now online
4 April 2024. Related: Conference reports.
Future meetings and webinars 2024/2025
1 April 2024. Related: Future meetings.
CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda
24 March 2024. Related: Conference reports, Treatment access, Women's health, Pregnancy, Vaccines and microbicides.
Roche to discontinue enfuvirtide (T-20, Fuzeon)
24 March 2024. Related: Antiretrovirals.
CROI 2024: Pipeline ART – new drugs and formulations
19 March 2024. Related: Conference reports, Antiretrovirals.
CROI 2024: Studies using tecovirimat to treat mpox
16 March 2024. Related: Conference reports, mpox (monkeypox).
CROI 2024: Promising results from first study of long-acting treatment in Africa
10 March 2024. Related: Conference reports, Antiretrovirals, Treatment access.
CROI 2024: HIV studies with semaglutide: significant benefits but limited access for treatment and research
10 March 2024. Related: Conference reports, Lipodystrophy and metabolic complications.
CROI 2024: studies to watch for at this upcoming conference
1 March 2024. Related: Conference reports.
US guidelines recommend earlier use of statins in people living with HIV
1 March 2024. Related: Guidelines, Lipodystrophy and metabolic complications.
Featured UK guide to PrEP now online: major update (2024)
1 March 2024. Related: Editorial, Special reports.
Modelling study challenges links between gender and PrEP: event-based dosing and easier daily dosing should work for all
12 February 2024. Related: Special reports, HIV prevention and transmission.
UK HIV Positive Voices survey: many people doing well but life is still difficult for others; growing belief in U=U
9 February 2024. Related: Special reports, Ageing and life expectancy, Treatment advocacy, Research studies, Other news.
Mpox updates: recent publications (2024)
2 February 2024. Related: mpox (monkeypox).
Remarkable impact of DNDi over 20 years
24 January 2024. Related: Other news, On the web.
BHIVA recommendations on measles in the UK
23 January 2024. Related: Guidelines, Coinfections and complications, BHIVA news.
Liverpool Drug Interactions: January update
17 January 2024. Related: PK and drug interactions.
Five cases of viral failure on CAB-LA and RPV-LA injections
15 January 2024. Related: Antiretrovirals, Drug resistance.
Clinical efficacy of tecovirimat for treatment of mpox in people living with HIV
10 January 2024. Related: mpox (monkeypox).
BHIVA update guidance on shingles vaccine
9 January 2024. Related: Guidelines, Coinfections and complications, Basic science and immunology, Vaccines and microbicides, BHIVA news.
PrEP douche achieves more protective drug levels than 2:1:1 oral dosing
9 January 2024. Related: HIV prevention and transmission.
Uganda hate law blocks HIV research: join 300 leading researchers in sign-on protest
4 January 2024. Related: Special reports, Treatment access, Treatment advocacy, Research studies.
Featured HTB 2024: weekly news posted online
3 January 2024. Related: Editorial.
Uganda update: LGBT hate law challenged in the courts
3 January 2024. Related: Special reports, Treatment advocacy.